Catalyst Wire Dossier Catalyst Wire Dossier

Reamberin

· POLYSAN Scientific & Technological Pharmaceutical Company
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Reamberin, covering 2025-04-18 to 2025-07-15. Get the full timeline:

Most recent: Clinical Trial Update: Trial of the Efficacy and Safety of Use of Drug Product Reamberin® for Pathogenetic Therapy of Viral Enteric Infection in Children Aged 1-6 Years Old

See pricing